Evidence map›Paper›PMID 24308006›Full record

ReviewBioMed research international2013

Propionibacterium acnes: an underestimated pathogen in implant-associated infections.

María Eugenia Portillo, Stéphane Corvec, Olivier Borens, Andrej Trampuz

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03849885 (Cutibacterium Dermal Colonization), which is not on this map. Cited by 117 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed, 1 pooled it
18.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03849885 phase4unknown statusnot on this mapstarted 2019, after this paper: background citation

Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

TypeinterventionalSponsorColorado Joint ReplacementRan2019 to 2024Enrolled496ConditionsDegenerative OsteoarthritisArmsBenzoyl peroxide gel
3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 1 synthesis or guideline pooled it, 251 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. European heart journal. Case reports · 2026
    Article
  6. Antibiotics (Basel, Switzerland) · 2026
    Article
  7. Mixed infection withFrontiers in medicine · 2026
    Article
  8. Article
  9. Biology · 2025
    Review
  10. Article
  11. Bacterial skin colonization with a specificMicrobiology spectrum · 2025
    Article
  12. The Role ofInternational journal of molecular sciences · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  18. Does hydrogen peroxide help mitigate the incidence ofNorth American Spine Society journal · 2024
    Article
  19. Frontiers in immunology · 2024
    Article
  20. Comparative Genomic Analysis ofMicroorganisms · 2023
    Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

María Eugenia PortilloMicrobiology Laboratory, Laboratori de Referencia de Catalunya, Barcelona, Spain.
Stéphane Corvec
Olivier Borens
Andrej Trampuz
Centre Hospitalier Universitaire de Nantes · FRHumboldt-Universität zu Berlin · DEUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of Propionibacterium acnes in acne and in a wide range of inflammatory diseases is well established. However, P. acnes is also responsible for infections involving implants. Prolonged aerobic and anaerobic agar cultures for 14 days and broth cultures increase the detection rate. In this paper, we review the pathogenic role of P. acnes in implant-associated infections such as prosthetic joints, cardiac devices, breast implants, intraocular lenses, neurosurgical devices, and spine implants. The management of severe infections caused by P. acnes involves a combination of antimicrobial and surgical treatment (often removal of the device). Intravenous penicillin G and ceftriaxone are the first choice for serious infections, with vancomycin and daptomycin as alternatives, and amoxicillin, rifampicin, clindamycin, tetracycline, and levofloxacin for oral treatment. Sonication of explanted prosthetic material improves the diagnosis of implant-associated infections. Molecular methods may further increase the sensitivity of P. acnes detection. Coating of implants with antimicrobial substances could avoid or limit colonization of the surface and thereby reduce the risk of biofilm formation during severe infections. Our understanding of the role of P. acnes in human diseases will likely continue to increase as new associations and pathogenic mechanisms are discovered.

Indexed as

Host-Pathogen InteractionsAnimalsAnti-Bacterial AgentsGram-Positive Bacterial InfectionsHumansPropionibacterium acnesProstheses and ImplantsAnti-Bacterial Agents

Identifiers

PMID24308006
PMCPMC3838805
OpenAlexW2113010344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.